UK Market
About TheraCryf Plc
This clinical stage drug company develops sulforaphane-based medicines for the treatment of multiple diseases.This stock may have lower liquidity and trading may be extremely volatile, with a higher likelihood of rejected orders. Less liquid stocks often have a broader spread between the price at which you will be able to sell or buy a stock. If using market orders, please be aware that there is a risk that the price at which your order is filled could significantly differ from the last displayed price in the app.
Health
Sector
